Evaluate the liver injury in COVID-19 patients at government medical college and hospital, Ambikapur

Abstract

A pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or novel coronavirus disease (COVID-19) began in December 2019 in China's Wuhan region and spread worldwide by April 2020, affecting 187 of the world's 192 countries with varied degrees of severity. When alanine aminotransferase (ALT) was > 55 U/l or total bilirubin was > 1.6 mg/dl, a patient was regarded to have liver damage. For laboratory data, the Spearman correlation coefficient was calculated, and bivariable analysis for mortality and/or the need for intensive care was performed. Aim: To evaluate the liver injury in covid-19 patients at government medical college and hospital. Methods and Materials: All the Patients were admitted in Covid ward at Govt. medical college and hospital, Ambikapur, Chhattisgarh. India. Present study were divided into two groups. Group-I: Female COVID Positive Patients -20, Group-II –Male COVID positive Patients -20.Conclusion: To summarise, patients with COVID-19 in Ambikapur, Chattisgarh, had a significant rate of abnormal liver function tests, which was linked to poorer outcomes when they developed severe acute respiratory distress syndrome.